diallyl trisulfide has been researched along with cardiovascular agents in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, CY; Kuang, SJ; Li, XH; Lin, QX; Lin, SG; Liu, XY; Rao, F; Shan, ZX; Wu, SL; Yang, M; Yu, XY; Zhou, ZL | 1 |
1 other study(ies) available for diallyl trisulfide and cardiovascular agents
| Article | Year |
|---|---|
Allitridi inhibits transient outward potassium currents in human atrial myocytes.
Topics: Action Potentials; Adult; Aged; Allyl Compounds; Atrial Function; Cardiovascular Agents; Drug Evaluation, Preclinical; Electrophysiology; Heart Atria; Humans; Membrane Potentials; Middle Aged; Myocytes, Cardiac; Potassium Channels; Sulfides | 2011 |